151. IgG antispike persistence and immunophenotype in children infected by SARS‐CoV‐2.
- Author
-
García‐Salido, Alberto, Flores‐Pérez, Patricia, González‐Murillo, África, Sánchez‐Marcos, Elena, Leoz‐Gordillo, Inés, Cano‐Fernández, Julia, Castillo‐Robleda, Ana, Nieto‐Moro, Montserrat, and Jiménez‐García, Raquel
- Subjects
IMMUNITY ,SARS-CoV-2 ,LEUCOCYTES ,IMMUNOASSAY ,CD45 antigen - Abstract
Aim: The immune status of children recovering from SARS‐CoV‐2 infection is not completely understood. We describe IgG antispike persistence in children infected during the first two pandemic waves. In addition, we compared with healthy controls their leukocyte populations and CD64 expression. Methods: Cross‐sectional study. Carried out from October 2021 to February 2022 in nonreinfected and nonvaccinated children with SARS‐CoV‐2 in 2020. The presence of antispike IgG was studied using chemiluminescent immunoassay. Leukocyte populations were analysed using flow cytometry and marked for CD45, CD4, CD8 and CD64. Statistical minor than 0.05 was considered significant. Results: One hundred and eighty‐three control and 77 patients were included. IgG antispike determinations were performed after a median of 501 days (262–464); 52 of 77 children were positive. Cases showed significantly higher percentages of monocytes, lymphocytes, CD8+ and CD4+. In addition, CD64 expression was higher in monocytes and neutrophils. The presence of IgG antispike was accompanied by a higher percentage of CD64+ neutrophils. Conclusion: In our series, the SARS‐CoV‐2 IgG antispike protein was usually positive beyond 1 year after infection. Furthermore, leukocyte populations from cases differ from controls, with higher CD64 expression on neutrophils and monocytes. Prospective clinical observations are required to confirm the implications of these findings. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF